HLA-DQB1* polymorphism and associations with dilated cardiomyopathy, inflammatory dilated cardiomyopathy and myocarditis

Autoimmunity

Volumn 42, Issue 1, 2009, Pages 33-40

  Portig, Irene ^a   Sandmoeller, Andrea ^a   Kreilinger, Sabine ^a   Maisch, Bernhard ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cardiomyopathy; HLA DQB1; Inflammatory DCM; Myocarditis

Indexed keywords

HLA DQB1 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; HLA DQ ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; HEART LEFT VENTRICLE FUNCTION; HLA TYPING; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; INFLAMMATORY DILATED CARDIOMYOPATHY; MALE; MYOCARDITIS; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; ADOLESCENT; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEART MUSCLE; IMMUNOLOGY; INFLAMMATION; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHY, DILATED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ ANTIGENS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM; POLYMORPHISM, GENETIC; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 58149481806     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930802258651     Document Type: Article

References (49)

1. Richardson, P., McKenna, W., Bristow, M., Maisch, B., Mautner, B., O'Connell, J., Olsen, E., Thiene, G., Goodwin, J., Gyarfas, I., Martin, I. and Nordet, P. (1996) Report of the 1995 World Health Organisation/ International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation, 93, pp. 841-842.
2. Cohn, JN, Bristow, MR, Chien, KR, Colucci, WS, Frazier, OH, Leinwand, LA, Lorell, BH, Moss, AJ, Sonnenblick, EH, Walsh, RA, Mockrin, SC and Reinlib, L. (1997) Report of the national heart, lung, and blood institute special emphasis panel on heart failure research. Circulation, 95, pp. 766-770.
3. Felker, GM, Thompson, RE, Hare, JM, Hruban, RH, Clemetson, DE, Howard, DL, Baughman, KL and Kasper, EK (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med, 342, pp. 1077-1084.
4. Mestroni, L., Rocco, C., Gregori, D., Sinagra, G., Di Lenarda, A, Miocic, S., Vatta, M., Pinamonti, B., Muntoni, F., Caforio, AL, McKenna, WJ, Falaschi, A., Giacca, M. and Camerini, F. (1999) Familial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity. Heart muscle disease study group. J Am Coll Cardiol, 34, pp. 181-190.
5. Towbin, JA and Bowles, NE (2000) Genetic abnormalities responsible for dilated cardiomyopathy. Curr Cardiol Rep, 2, pp. 475-480.
6. Bowles, NE, Ni, J., Kearney, DL, Pauschinger, M., Schultheiss, HP, McCarthy, R., Hare, J., Bricker, JT, Bowles, KR and Towbin, JA (2003) Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol, 42, pp. 466-472.
7. Rose, NR, Herskowitz, A., Neumann, DA and Neu, N. (1988) Autoimmune myocarditis: A paradigm of post-infectious autoimmune disease. Immunol Today, 9, pp. 117-120.
8. Maisch, B., Ristic, AD, Hufnagel, G. and Pankuweit, S. (2002) Pathophysiology of viral myocarditis. The role of humoral response. Cardiovasc Pathol, 11, pp. 112-122.
9. Nakamura, H., Yamamura, T., Umemoto, S., Fukuta, S., Shioi, T., Matsumori, A., Sasayama, S. and Matsuzaki, M. (1996) Autoimmune response in chronic ongoing myocarditis demonstrated by heterotopic cardiac transplantation in mice. Circulation, 94, pp. 3348-3354.
10. Liu, PP and Mason, JW (2001) Advances in the understanding of myocarditis. Circulation, 104, pp. 1076-1082.
11. Eriksson, U., Ricci, R., Hunziker, L., Kurrer, MO, Oudit, GY, Watts, TH, Sonderegger, I., Bachmeier, K., Kopf, M. and Penninger, JM (2003) Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med, 9, pp. 1448-1490.
12. McKenna, CJ, Codd, MB, McCann, HA and Sugrue, DD (1997) Idiopathic dilated cardiomyopathy: Familial prevalence and HLA distribution. Heart, 77, pp. 549-552.
13. Pankuweit, S., Portig, I., Lottspeich, F. and Maisch, B. (1997) Autoantibodies in sera of patients with myocarditis: Characterisation of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J Mol Cell Cardiol, 29, pp. 77-84.
14. Portig, I., Pankuweit, S. and Maisch, B. (1997) Antibodies against stress proteins in sera of patients with dilated cardiomyopathy. J Mol Cell Cardiol, 29, pp. 2245-2251.
15. Schultheiss, HP, Schulze, K., Kuhl, U., Ulrich, G. and Klingenberg, M. (1986) The ADP/ATP carrier as a mitochondrial auto-antigen-facts and perspectives. Ann NY Acad Sci, 488, pp. 44-64.
16. Caforio, AL, Mahon, NJ, Tona, F. and McKenna, WJ (2002) Circulating autoantibodies in dilated cardiomyopathy and myocarditis: Pathogenetic and clinical significance. Eur J Heart Fail, 4, pp. 411-417.
17. Limas, CJ, Iakovis, P., Anyfantakis, A., Kroupis, C. and Cokkinos, DV (2004) Familial clustering of autoimmune disease in patients with dilated cardiomyopathy. Am J Cardiol, 93, pp. 1189-1191.
18. Taylor, JA, Havari, E., McInerney, MF, Wucherpfennig, KW and Lipes, MA (2004) A spontanous model for autoimmune myocarditis using the human MHC molecule HLA-DQ8. J Immunol, 172, pp. 2651-2658.
19. Liu, J., Purdy, LE, Rabinovitch, S., Jevnikar, AM and Elliott, JF (1999) Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice. Diabetes, 48, pp. 469-477.
20. Carlquist, JF, Menlove, RL, Murray, MB, O'Connell, JB and Anderson, JL (1991) HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Circulation, 83, pp. 515-522.
21. Aretz, HT (1987) Myocarditis: The Dallas criteria. Hum Pathol, 18, pp. 619-662.
22. Portig, I., Wilke, A., Freyland, M., Wolf, M., Richter, A., Ruppert, V., Pankuweit, S. and Maisch, B. (2006) Familial inflammatory dilated cardiomyopathy. Eur J Heart Fail, 8, pp. 816-825.
23. Mueller, CR, Goldmann, SF and Wegener, S. (1998) Population studies. German normal. HLA 1998, pp. 154-157. American Society for Histocompatibility and Immunogenetics, Lenexa, Kansas
24. Pankuweit, S., Portig, I., Eckhardt, H., Crombach, M., Hufnagel, G. and Maisch, B. (2000) Prevalence of viral genome in endomyocardial biopsies from patients with inflammatory heart muscle disease. Herz, 25, pp. 221-226.
25. Olerup, O. and Zetterquist, H. (1992) HLA-DR typing by PCR amplification with SSP-PCR in two hours: An alternative to serological DR typing in clinical practice including donor-recipient match in cadaveric transplantation. Tissue Antigens, 39, pp. 225-235.
26. Lozano, MD, Rubocki, RJ, Wilson, JE, McManus, BM and Wisecarver, JL (1997) Human leukocyte antigen class II associations in patients with idiopathic dilated cardiomyopathy. Myocarditis treatment trial investigators. J Card Fail, 3, pp. 97-103.
27. Nishi, H., Koga, Y., Koyanage, T., Harada, H., Imaizumi, T., Tosjima, H., Sazuki, T. and Kimura, A. (1995) DNA typing of HLA class II genes in Japanese patients with dilated cardiomyopathy. J Mol Cell Cardiol, 27, pp. 2385-2392.
28. Liu, W., Li, WM and Sun, NL (2005) HLA-DQA1, -DQB1 polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy in Hans of northern China. Ann Hum Genet, 69, pp. 382-388.
29. Limas, CJ, Limas, C., Goldenberg, IF and Blair, R. (1995) Possible involvement of the HLA-DQB1 gene in susceptibility and resistance to human dilated cardiomyopathy. Am Heart J, 129, pp. 1141-1144.
30. Ghodke, Y., Joshi, K., Chopra, A. and Patwardhan, B. (2005) HLA and disease. Eur J Epidemiol, 20, pp. 475-488.
31. Hauck, AJ, Kearney, DL and Edwards, WD (1989) Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: Implications for role of sampling error. Mayo Clin Proc, 64, pp. 1235-1245.
32. Arif, S., Underhill, JA, Donaldson, P., Conway, GS and Peakman, M. (1999) Human leukocyte antigen-DQB1* genotypes encoding aspartate at position 57 are associated with 3beta-hydroxysteroid dehydrogenase autoimmunity in premature ovarian failure. J Clin Endocrinol Metab, 84, pp. 1056-1060.
33. Yunis, JJ, Mobini, N., Yunis, EJ, Alper, CA, Deulofeut, R., Rodriguez, A., Foster, CS, Marcus-Bagley, D., Good, RA and Ahmed, AR (1994) Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid. Proc Natl Acad Sci USA, 91, pp. 7747-7751.
34. Delgado, J., Turbay, D., Yunis, EJ, Yunis, JJ, Morton, ED, Bhol, K., Norman, R., Alper, CA, Good, RA and Ahmed, R. (1996) A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci USA, 93, pp. 8569-8571.
35. Thursz, M., Yallop, R., Goldin, R., Trepo, C. and Thomas, HC (1999) Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet, 354, pp. 2119-2124.
36. Voorter, CE, Drent, M. and van den Berg-Loonen, EM (2005) Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1*0602-DRB1*150101. Hum Immunol, 66, pp. 826-835.
37. Fernandez, O., Fernandez, V., Alonso, A., Caballero, A., Luque, G., Bravo, M., Leon, A., Mayorga, C., Leyva, L. and de Ramon, E. (2004) DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga. Spain J Neurol, 251, pp. 440-444.
38. Matsuki, K., Grumet, FC, Lin, X., Gelb, M., Guilleminault, C., Dement, WC and Mignot, E. (1992) DQ (rather than DR) gene marks susceptibility to narcolepsy. Lancet, 339, p. 1052.
39. Kotb, M., Norrby-Teglund, A., McGeer, A., El-Sherbini, H., Dorak, MT, Khurshid, A., Green, K., Peeples, J., Wade, J., Thomson, G., Schwartz, B. and Low, DE (2002) An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med, 8, pp. 1398-1404.
40. Todd, JA, Bell, JI and McDevitt, HO (1987) HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature, 329, pp. 599-604.
41. Smyth, CM, McKiernan, SM, Hagan, R., Pilkington, R., O'Regan, M., Lawlor, E. and Kelleher, D. (2007) Chronic hepatitis C infection and sicca syndrome: A clear association with HLA DQB1*02. Eur J Gastroenterol Hepatol, 19, pp. 493-498.
42. Sumnik, Z., Cinek, O., Tratanic, N., Kordonouri, O., Kulich, M., Roszai, B., Arato, A., Lebl, J., Soltesz, G., Danne, T., Battelino, T. and Schober, E. (2006) Risk of celiac disease in children with type 1 diabetes is modified by positivity for HLA-DQB1*02-DQA1*05 and TNF -308A. Diabetes Care, 29, pp. 858-863.
43. Craig, ME, Howard, NJ, Silink, M. and Rawlinson, WD (2003) Reduced frequency of HLA DRB1*03-DQB1*02 in children with type 1 diabetes associated with enterovirus RNA. J Infect Dis, 187, pp. 1562-1570.
44. Martin, AM, Nolan, D., Gaudieri, S., Almeida, CA, Nolan, R., James, I., Carvalho, F., Phillips, E., Christiansen, FT, Purcell, AW, McCluskey, J. and Mallal, S. (2004) Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proc Natl Acad Sci USA, 101, pp. 4180-4185.
45. Jones, EY, Fugger, L., Strominger, JL and Siebold, C. (2006) MHC class II proteins and disease: A structural perspective. Nat Rev Immunol, 6, pp. 271-282.
46. Smith, SC and Allen, PM (1992) Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis. Proc Natl Acad Sci USA, 89, pp. 9131-9135.
47. Nadal-Ginard, B., Kajstura, J., Anversa, P. and Leri, A. (2003) A matter of life and death: Cardiac myocyte apoptosis and regeneration. J Clin Invest, 111, pp. 1457-1459.
48. Dorffel, WV, Wallukat, G., Dorffel, Y., Felix, SB and Baumann, G. (2004) Immunoadsorption in idiopathic dilated cardiomyopathy, a 3-year follow-up. Int J Cardiol, 97, pp. 529-534.
49. Vally, M., Seenu, S. and Pillarisetti, S. (2006) Emerging peptide therapeutics for inflammatory diseases. Curr Pharm Biotechnol, 7, pp. 241-246.